FDA updates safety guidance for aesthetic radiofrequency devices

On August 9, 2026, the FDA issued its revised Aesthetic RF Devices: Safety Assessment Guidance (Rev. 2) document, which shifts how new radiofrequency technology is cleared for our clinics. Starting September 1, 2026, any new multi-polar or monopolar RF anti-aging devices entering the U.S. market must include a comprehensive thermal injury risk assessment report. This assessment must be based on the IEC 60601-2-57 Annex DD standard. Crucially, manufacturers must provide validation data demonstrating real-time monitoring of skin surface temperature during use. Because these requirements apply to both professional-grade systems and home-use devices, they immediately impact pending pre-market 510(k) filings. For clinics planning to purchase new RF platforms or HIFU lifting devices, this regulatory shift means we should expect pipeline delays as manufacturers update their testing and submissions. If you are negotiating a capital equipment purchase, you should ask vendors for their specific validation data and compliance status under the updated guidance to avoid shipping and installation holdups.

Source: Global Trade Draft HQ, https://www.globaltradedrafthq.com